SUMMARY
INTRODUCTION
Transbronchial needle aspiration (TBNA) is a minimally invasive technique for lymph node (LN) sampling to investigate etiologies of mediastinal and hilar LNs. Although TBNA was firstly described in 1949, fiberoptic bronchoscopic application was defined in 1981 (1, 2) . Besides conventional usage with white light bronchoscopy (C-TBNA), its bronchoscopic appliance can also be guided by newer imaging methods like endobronchial ultrasound (EBUS-TBNA).
Conventional TBNA is a minimally invasive, safe, and cost-effective technique in evaluating mediastinal and enlarged LNs. Emergence and increasing use of EBUS-TBNA provided more information about this newer technique's diagnostic success and gave the opportunity to compare it with that of C-TBNA. The meta-analyses performed for the 3 rd edition of American College of Chest Physicians (ACCP) Diagnosis and Management of Lung Cancer Guideline yielded mean pooled sensitivities of 78% and 89% for C-TBNA and EBUS-TBNA, respectively (3) . There are randomized trials with results suggesting better diagnostic results with EBUS-TBNA in both lung cancer and sarcoidosis patients (4) (5) (6) . Despite better diagnostic results of TBNA with additional imaging, requirement for advanced devices, special equipment and experienced staff for the specific procedure makes wide range application of those techniques uneasy (7) . Thus, C-TBNA may still be important for LN sampling in terms of feasibility and practicality. Herein we report the diagnostic yield (DY) and safety of C-TBNA performed in a single center at a university clinic.
PATIENTS and METHODS

Patients
The study included 363 consecutively performed C-TBNA procedures in 219 patients who underwent fiberoptic bronchoscopy and C-TBNA in the Bronchoscopy Unit of Hacettepe University Adult Hospital between October 1 st , 2012 and December 31 st , 2014. With the retrospective design, the study was approved by Hacettepe University Non-interventional Clinical Researches Ethical Committee. The files of the patients were reviewed retrospectively and available study forms were duly filled in. The age, gender, radiological findings, bronchoscopic findings, sampled LN stations, complications related to procedure, cytological findings, and final diagnoses were recorded on these forms. If available, short axis diameter on computed tomography (CT) of thorax and maximum standardized uptake values (SUVmax) on integrated positron emission tomography and CT (PET/CT) were recorded for LNs that were sampled by C-TBNA.
C-TBNA Procedure
Conventional TBNAs were performed by experienced bronchoscopists and residents under their supervision. The procedures were performed with 22-gauge cytology needles of two brands: 1) Wang MW-122 of Bard-Wang, Billerica, Mass., USA, 2) Matek TBN0122 of Matek Medical, Ostim, Ankara, Turkey. Procedures were performed without an on-site cytopathologist. Although exact numbers weren't recorded, all LN stations were sampled at least three times. The aspirates were rapidly placed on a glass slide, which was then covered with a second slide, and while applying minimal continuous pressure, the slides were drawn apart. After air-drying, the smears were transported to the cytopathology unit for staining and evaluation. Air-dried slides were stained with MayGrünwald Gimsa (MGG) stain.
Cytological Assessments
All cytological samples were evaluated by a single experienced cytopathologist. If more than one station was sampled in a patient, each station's cytological result was recorded separately. Cytological samples were considered as diagnostic if they represented a lymph node, which is characterized by the presence of abundant lymphoid cells of polymorphous appearance. Cytological results revealing malignant cells and granulomatous inflammation were considered as specifically diagnostic for a pathological process. Cytological results revealing polymorphous lymphocytes without any other findings like granulomatous inflammation or malignant cells were also considered as diagnostic, but represented a reactionary lymph node. Cytological results revealing only bronchial epithelial cells, mucus, blood elements or inadequate cytological material were considered as non-diagnostic. Such cases were already categorized as non-diagnostic with a note on cytology reports. If cytological findings revealed specific malignancy types, these results were also recorded.
Statistical Analysis
Statistical analyses were performed by using IBM SPSS for Windows Version 21.0 statistical software package. Continuous variables presented as mean ± standard deviation (minimum-maximum). Categorical variables summarized as frequencies and percentages. Normality of the continuous variables was evaluated by Shapiro Wilks test. Differences between groups according to categorical variables were determined by chi-square and Fisher's exact tests and differences between the two groups according to continuous variables were determined by Mann-WhitneyWilcoxon test. Pearson correlation coefficient was used to show the relation between continuous variables. ROC curve analysis was used to show the diagnostic value of TBNA for certain LN diameter cutoff values. The sensitivity (SEN), specificity (SPE), negative predictive and positive predictive values (NPV and PPV) were calculated for these cut-offs. A p value less than 0.05 described as statistically significant.
RESULTS
The study included 219 patients (male/female: 148/71, mean age: 57 ± 13.6 years). Of 363 C-TBNA procedures, sampled stations were subcarinal in 164 (45.2%), right paratracheal in 121 (33.3%), right hilar in 58 (16%), left hilar in 13 (3.6%), and left paratracheal in 7 (1.9%) ( Table 1 ). The DY of C-TBNA was 77.4% in subcarinal, 64.5% in right paratracheal, 71.4% in left paratracheal, 67.2% in right hilar, and 61.5% in left hilar LNs. There was no statistically significant relationship between DY and sampled LN station (p= 0.12). Conventional TBNA was diagnostic in 257 (71%) and non-diagnostic in 106 (29%) LNs. The diagnoses were malignancy in 109 (30%), granulomatous inflammation in 68 (18.7%), cystic fluid aspiration in 2 (0.6%), and reactionary lympadenopathy in 78 LNs (21.5%) ( Table 2) . A specific diagnostic result was obtained in 179 (49.3%) procedures totally. Of these procedures, 109 (30%) were malignancy and 70 (19.3%) were benign disorders. The procedures revealing granulomatous inflammation were compatible with sarcoidosis in 61, tuberculosis in 3, and granulomatous inflammation accompanied by malignancy in 4 procedures In Figure  1 , the CT sections and cytological examinations of three patients with the diagnoses of adenocarcinoma, squamous cell carcinoma and sarcoidosis are presented. Apart from minor bleeding at biopsy sites, no major complication occurred due to C-TBNA.
DISCUSSION
In this study, we retrospectively reviewed 363 consecutive C-TBNA procedures in 219 patients. The primary aim was to evaluate the DY of C-TBNA and after that to evaluate the association of DY with the location of LN, the shortest diameter, SUVmax of LN, and the number of sampled stations. We did not verify all of our results with invasive methods such as mediastinoscopy or surgery, since the primary aim was to find out the characteristics of LNs that we are capable of sampling adequately for diagnosis. For this reason cytological results revealing abundant polymorphic lymphocytes representing LN were also considered as diagnostic. It is a reality that this group might contain false negative diagnoses, since C-TBNA is just a diagnostic procedure with a low sensitivity, but 100% specificity (3). The DY of 363 procedures in 219 patients was 71%. The ratio of patients with at least one diagnostic C-TBNA procedure was 77%. While the ratio of procedures with a specific diagnosis was 49.3%, the ratio of benign reactionary LNs was 21.5%.
Conventional TBNA has been proven to be a safe, minimally invasive, and cost-effective technique for sampling mediastinal LNs. In addition to the equipment needed for bronchoscopy, TBNA needles are used. These needles are designed to pass through a bronchoscope without causing damage and are flexible enough to facilitate the positioning of the bronchoscope, yet rigid enough to penetrate the airway wall. There are two types of TBNA needles known as flexible cytology and rigid histology needles. In a prospective study including 138 consecutive patients with bronchogenic carcinoma and amenable to surgical procedures, all 8 mm and larger mediastinal/hilar LNs determined before bronchoscopy by CT were sampled by 18-gauge rigid and 21-gauge flexible TBNAs in the same session. The sensitivities of rigid and flexible TBNAs were 74 and 70%, respectively (p> 0.05), but both had a specificity of 100% (8) . In another study investigating the diagnostic value of 22-gauge Wang TBNA cytology needles in patients with mediastinal and/or hilar adenopathy, adequate lymph node sampling was obtained from 59 of 60 patients (98%), a specific diagnosis was obtained in 45 of 60 patients (75%) (9) . In this study, we also used 22-gauge flexible cytology needles.
The DY of C-TBNA varies considerably among various studies. ACCP 2013 guideline for lung cancer found a mean pooled sensitivity of C-TBNA as 78%, ranging from 14 to 100% in terms of lung cancer (3). Studies including patients with suspicion of sarcoidosis have diagnostic sensitivities ranging from 72 to 90% (10) (11) (12) . In a study including 34 patients, C-TBNA revealed a definite diagnosis in 14 patients (41.1%) and C-TBNA had a higher DY for malignancy (64.7%) compared to non-malignant diseases (17.6%) (13). Although our study included an unselected patient population in terms of suspected etiology, our DY of 71% is similar to results in the literature. The most frequent diagnoses were malignancy followed by granulomatous inflammation. Based on these findings, we claim that C-TBNA should be considered in the diagnosis of mediastinal and hilar LNs before other more invasive procedures such as mediastinoscopy or surgery.
There are substantial amount of studies in the literature to investigate predictors of diagnostic C-TBNA. Those studies differ in terms of study designs (e.g. retrospective studies, prospective case series, and randomized controlled trials) and selected patient populations. Some of the studies include unselected patient populations whereas others include patients with specific etiologies like malignancy or sarcoidosis. Systematic review of Bonifazi et al. aiming to identify predictors successful TBNA aspirations and to definet hose predictors for different patient populations found LN size (≥ 2 cm for several studies), type of disease, operator experience, endoscopic findings, needle size, number of needle passes (> 3), and LN station (subcarinal and right paratracheal) as factors with strong predictive roles for unselected population (7) . In another study investigating the DY of C-TBNA by size, the DY was 0% when the LN diameter was < 2 cm, 63.6% when ≥ 2 cm (13). In our study, there was no significant relationship between sampled LN station and DY. But the cut-off values 11.5 mm for all LNs and 10.5 mm for subcarinal LN were lower than 2 cm. Mean LN diameters were significantly different between diagnostic and non-diagnostic results (17.7 vs 14.2 mm, p< 0.001). The cut-off diameters for certain stations are important for choosing the sampling procedure EBUS-TBNA for smaller LNs, C-TBNA for larger ones.
In this study, we performed C-TBNAs from subcarinal, paratracheal, and hilar LNs. Subcarinal region was there most commonly sampled station and our best diagnostic results were achieved in there subcarinal station (77.4%). This result is probably due to two reasons. Firstly, based on technical reasons it is easy to sample subcarinal LNs. Secondly, it is important to sample subcarinal LNs for lung cancer staging as it indicates N2 disease (14) . There was also a significant relationship between number of sampled LNs and DY (p= 0.033). This finding indicates the importance of sampling more than one station for patients with LAPs in different stations if technically available.
As an advanced imaging method, PET/CT is increasingly used for radiological staging of lung cancer. There are studies with results suggesting increased DY of C-TBNA with higher SUVmax on PET/CT, but these studies define diverse range of SUVmax cut-offs such as 2.5, 3 and 5 (15) (16) (17) . In this study, a limited percentage of patients (34.9%) had undergone PET/CT. There was a better DY with increasing SUVmax on PET/CT with a nearly significant relationship for a cut-off SUVmax 4.8.
Conventional TBNA is known as a safe procedure with a very low incidence of complications. The most common potential complications are bleeding, pneumothorax, or pneumomediastinum. Significant bleeding rarely occurs even after a major vessel puncture. Meta-analysis of Holty et al. found overall major complication rate (two major bleeds and one pneumothorax requiring chest tube) as 0.26% (18) . Fever, bacteremia and hemomediastinum are other reported complications after TBNA procedures (19, 20) . In our study there was no major complication occurred due to C-TBNA.
Conventional TBNA has been used for over 30 years to obtain histologic and cytological specimens from mediastinal LNs with sensitivities approaching 80-90% (3). Recently EBUS-TBNA has demonstrated even higher sensitivities among experts (21, 22) . However EBUS-TBNA is more complicated, requires additional training, less well tolerated by patients and more costly than C-TBNA (23).
Our study's strengths include similarity of bronchoscopist experience for each procedure, analysis of both malignant and non-malignant cytologies and evaluation of cytologic samples by the same experienced cytopathologist. Retrospective basis of our study is one of the limitations. Also, results didn't include any comparison between C-TBNA results with invasive pathological sampling methods like mediastinoscopy or thoracotomy. Analyses were mainly done to evaluate sampling success, thus adequate samples without any specific diagnoses may require further diagnostic procedures. Procedurerelated factors like endoscopic findings, needle brand, number of needle passes weren't analyzed. Also there wasn't any analysis based on pre-procedural suspected etiology and final diagnosis of patient.
CONCLUSION
Conventional TBNA is an effective and safe procedure for investigating both malignant and non-malignant etiologies of mediastinal and hilar LNs. Diagnostic success of procedure is increased with number of sampled LNs, larger LN diameter (> 11.5 mm) and increased SUVmax on PET/CT. Despite its feasibility advantages, results of studies comparing EBUS-TBNA and C-TBNA favor EBUS-TBNA in terms of diagnostic yield. In current conditions, further investigations and studies may be conducted to improve EBUS-TBNA's wide range application. With decreasing trend of clinical usage of C-TBNA, it may keep its importance for settings with limited resources.
